2019
Ten-Year Comparison Study of Type 1 and 2 Endometrial Cancers: Risk Factors and Outcomes
Feinberg J, Albright B, Black J, Lu L, Passarelli R, Gysler S, Whicker M, Altwerger G, Menderes G, Hui P, Santin AD, Azodi M, Silasi DA, Ratner ES, Litkouhi B, Schwartz PE. Ten-Year Comparison Study of Type 1 and 2 Endometrial Cancers: Risk Factors and Outcomes. Gynecologic And Obstetric Investigation 2019, 84: 290-297. PMID: 30602164, DOI: 10.1159/000493132.Peer-Reviewed Original ResearchConceptsType 2 cancerHormone replacement therapyCox regression modelType 2 diseaseRisk factorsEndometrial cancerType 1Use of HRTLess obese patientsBaseline risk factorsEndometrial cancer casesMajor cardiovascular diseasesObese patientsOral contraceptivesOverall survivalClinical courseDiabetes mellitusRetrospective reviewRegression modelsReplacement therapyCardiovascular diseaseCancer casesAdvanced stageHigh mortalityRecurrence
2014
Flutamide and Biomarkers in Women at High Risk for Ovarian Cancer: Preclinical and Clinical Evidence
Gruessner C, Gruessner A, Glaser K, AbuShahin N, Zhou Y, Laughren C, Wright H, Pinkerton S, Yi X, Stoffer J, Azodi M, Zheng W, Chambers SK. Flutamide and Biomarkers in Women at High Risk for Ovarian Cancer: Preclinical and Clinical Evidence. Cancer Prevention Research 2014, 7: 896-905. PMID: 24950779, PMCID: PMC4154987, DOI: 10.1158/1940-6207.capr-13-0408.Peer-Reviewed Original ResearchMeSH KeywordsAdultAndrogen AntagonistsAnimalsAntineoplastic Agents, HormonalArea Under CurveBiomarkers, TumorEnzyme-Linked Immunosorbent AssayFallopian Tube NeoplasmsFallopian TubesFemaleFlutamideGenetic Predisposition to DiseaseHumansImmunohistochemistryMacrophage Colony-Stimulating FactorMaleMiceMice, NudeMiddle AgedOvarian NeoplasmsOvariectomyOvaryReceptor, ErbB-4Risk FactorsROC CurveSalpingectomyConceptsOvarian endosalpingiosisOvarian stromaFlutamide treatmentOvarian cancerHigh riskBRCA carrier statusOvarian cancer initiationPhase II studyRole of androgensPelvic serous cancerEffect of flutamideOvarian cancer developmentCSF-1High predictive valueLogistic regression modelsAndrogen ablationII studySerous cancerTumor burdenClinical evidenceBRCA mutationsFallopian tubeCSF-1RMale miceAndrogen action
2011
The significance of perineural invasion in early-stage cervical cancer
ElSahwi KS, Barber E, Illuzzi J, Buza N, Ratner E, Silasi DA, Santin AD, Azodi M, Schwartz PE, Rutherford TJ. The significance of perineural invasion in early-stage cervical cancer. Gynecologic Oncology 2011, 123: 561-564. PMID: 21968340, DOI: 10.1016/j.ygyno.2011.08.028.Peer-Reviewed Original ResearchConceptsEarly cervical cancerPerineural invasionCervical cancerRisk factorsAdjuvant therapyEarly-stage cervical cancer patientsEarly-stage cervical cancerMultiple high-risk factorsAdjusted hazard ratioIndependent risk factorRetrospective chart reviewLymphovascular space invasionCervical cancer patientsLarger tumor sizeHigh-risk factorsChart reviewHazard ratioCervical stromaParametrial invasionWorse prognosisPoor prognosisSpace invasionTumor sizeMean ageTumor extension